Our Services

Our unique integrated business model, with it’s range of services and capabilities, provides us with an entry point to become the preferred partner to many of the world’s leading pharma and biotech companies.

Our expertise

Bionical Emas are the only Contract Research Organization to combine Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP).

Our unique integrated business model, with it’s range of services and capabilities, benefit many of the world’s leading pharma and biotech companies. This distinctive offering enables us to maximize access and generate evidence at every stage of the drug development pathway.

We have extensive experience across all phases of clinical research, with a rich history in rare disease, oncology/heme-oncology, and infectious diseases.

Clinical operations Regulatory affairs Pharmacovigilance Medical affairs Data management Biostatistics & clinical programming Clinical trial drug sourcing Global storage & distribution Secondary packaging & labelling Global project management Patient access Real world evidence

Case studies

Operational Considerations for Designing and Setting up a Site-less Decentralised Clinical Trial (DCT)

Global Oncology Phase 3 Rescue Study

Effective Pharmacovigilance & Regulatory EU and Australian Due Diligence, leading to operational and consultative support

How else can we help?

Discover more about the services and capabilities Bionical Emas has to offer